Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UFUR added to Iressa in NSCLC
NCT01037998Phase 2Completed
- Sponsor
- Taipei Veterans General Hospital
- Start
- Nov 2005
- Primary completion
- Dec 2009
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of tegafur in non-small cell lung cancer (NSCLC), sponsored by Taipei Veterans General Hospital. Started Nov 2005; status: completed.
02
Drugs
tegafur
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01037998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01037998.